Selin Yaman Seval/LinkedIn
Sep 25, 2026, 19:45
Selin Yaman Seval: ITP Is More Than a Low Platelet Count
Selin Yaman Seval, Marketing Lead, New Launches (Rare Blood Disorders and Hemaophilia) at Sanofi, shared a post on LinkedIn:
“ITP is more than a low platelet count — it’s a complex immune dysregulation that can impact patients’ daily lives in many ways.
Proud to stand with the ITP community, raise awareness, and keep patients at the heart of the conversation.”
Stay updated with Hemostasis Today.
-
Nov 9, 2026, 17:11Ken Kuang: Why Your Calves Are Called Your “Second Heart”?
-
Nov 9, 2026, 17:07Mert Dumantepe: Key Insights From The 8th Abu Dhabi International Vascular Conference
-
Nov 9, 2026, 16:57Amrita Sarkar: Exciting Advances in Hematology and Vascular Research at 54th Annual Philadelphia Workshop
-
Nov 9, 2026, 16:47Joey Boxer Samuels: Prolonged Sitting and Vein Thrombosis
-
Nov 9, 2026, 13:48PF4-ELISA–Negative HIT: Are We Missing a New Class of Anti-PF4 Immunothrombotic Disease?
-
Nov 9, 2026, 13:07Nandini Sadasivam: Gene Therapy for Sickle Cell Disease and Thalassaemia
-
Nov 9, 2026, 13:04Raising Awareness of Bleeding Disorders in Women and Girls – EHC
-
Nov 9, 2026, 12:59Rahul Bohra: Exploring the Complex Mechanisms of Sickle Cell Disease
-
Nov 9, 2026, 12:53Three Years of Movement and Thrombosis Awareness in the Czech Republic – World Thrombosis day